Denub 60mg Injection consists of the active ingredient Denosumab. It is a medication used to treat osteoporosis (denub 60mg injection for osteoporosis), characterized by weakened bones. It is also prescribed to prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases (denub 60mg injection for bone cancer). Denub 60mg Injection works by inhibiting a protein called RANK ligand, which plays a role in the breakdown of bone tissue. Studies have shown that it can significantly increase bone density, reducing fracture risk in postmenopausal women with osteoporosis and patients with cancer-related bone loss (denub 60mg injection benefits). Close monitoring of renal function may be necessary for patients with moderate renal impairment. Denub 60mg Injection composition includes Denosumab as its active component, and it should not be used in individuals with known hypersensitivity or allergic reactions to its components. Adequate calcium and vitamin D supplementation is required during the treatment. This medication is not approved for use in children and adolescents, and its safety and effectiveness in pediatric populations have not been established, so it is contraindicated in individuals under 18. Denub 60mg Injection should be used cautiously in individuals with pre-existing hypoparathyroidism, characterized by low parathyroid hormone levels. Patients may also discuss denub 60mg injection alternative options with their healthcare provider if Denosumab is not suitable. Denub 60mg Injection price may vary based on location and pharmacy, so check with your local supplier.